NewAmsterdam Pharma Company is a biotechnology company in the healthcare sector on NASDAQ, led by Michael Davidson, with a market cap of $4.2B. As of Q3 2025, 107% of shares are held by 134 institutional investors, with Frazier Life Sciences Management, L.P. as the largest holder at 14.83%.
Overview of institutional ownership in NAMS as of Q3 2025 with a market cap of $3.2B
Based on market cap of $3.2B as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in NAMS as of Q3 2025
| Institution | Position Value |
|---|---|
Frazier Life Sciences Management, L.P. Venture Capital | $475.0M 14.23% of portfolio |
B Bain Capital Life Sciences Investors, LLC Institution | $304.9M 20.26% of portfolio |
RA CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | $288.4M 3.58% of portfolio |
C Capital World Investors Institution | $279.4M 0.04% of portfolio |
FCPM III SERVICES B.V. Real Assets | $262.0M 52.36% of portfolio |
VIKING GLOBAL INVESTORS LP Hedge Fund•Long/Short | $184.2M 0.48% of portfolio |
FMR LLC Institution | $157.4M 0.01% of portfolio |
DEERFIELD MANAGEMENT CO /NY Hedge Fund•Long/Short | $121.3M 2.01% of portfolio |
JENNISON ASSOCIATES LLC Long Only Manager | $119.4M 0.07% of portfolio |
WELLINGTON MANAGEMENT CO LLP Long Only Manager | $114.3M 0.02% of portfolio |
Institutional buying and selling activity for NAMS in Q3 2025
| Institution | Net Bought |
|---|---|
FMR LLC Institution | +$103.3M +3.6M shares |
C Capital World Investors Institution | +$40.8M +1.4M shares |
JENNISON ASSOCIATES LLC Long Only Manager | +$35.6M +1.3M shares |
D Duquesne Family Office LLC Institution | +$31.0M +1.1M shares |
MORGAN STANLEY RIA/Wealth | +$24.5M +859.8K shares |
WELLINGTON MANAGEMENT CO LLP Long Only Manager | +$19.8M +697.1K shares |
Polar Capital Holdings Plc Long Only Manager | +$11.2M +393.9K shares |
F First Turn Management, LLC Hedge Fund•Long/Short | +$5.6M +195.9K shares |
A Artia Global Partners LP Hedge Fund•Long/Short | +$4.8M +167.5K shares |
HENDERSON GROUP PLC Institution | +$4.4M +155.0K shares |
| Institution | Net Sold |
|---|---|
FCPM III SERVICES B.V. Real Assets | −$40.4M −1.4M shares |
DEERFIELD MANAGEMENT CO /NY Hedge Fund•Long/Short | −$24.2M −849.3K shares |
Woodline Partners LP Hedge Fund•Long/Short | −$21.0M −739.3K shares |
Pictet Asset Management Holding SA Long Only Manager | −$14.9M −524.6K shares |
VIKING GLOBAL INVESTORS LP Hedge Fund•Long/Short | −$14.3M −503.0K shares |
A ADAGE CAPITAL PARTNERS GP LLC Institution | −$12.4M −436.4K shares |
S Siren, L.L.C. Institution | −$12.2M −428.5K shares |
UBS GLOBAL ASSET MANAGEMENT AMERICAS INC Long Only Manager | −$5.8M −320.8K shares |
R READYSTATE ASSET MANAGEMENT LP Hedge Fund•Multi-Strategy | −$5.6M −196.8K shares |
ALLIANCEBERNSTEIN L.P. Long Only Manager | −$5.4M −189.8K shares |
Institutions that initiated new positions or completely exited NAMS in Q3 2025
| Institution | Position Value |
|---|---|
PRICE T ROWE ASSOCIATES INC /MD/ Long Only Manager | $3.9M 138.3K shares |
N NEW YORK STATE COMMON RETIREMENT FUND Institution | $758.8K 26.7K shares |
ING INVESTMENT MANAGEMENT LLC Insurance Manager | $548.9K 19.3K shares |
T TD ASSET MANAGEMENT INC Institution | $511.9K 18.0K shares |
BANK OF MONTREAL /CAN/ Institution | $352.3K 12.4K shares |
LEUCADIA NATIONAL CORP Institution | $341.3K 12.0K shares |
$233.6K 8.2K shares | |
M MARSHALL FINANCIAL GROUP INC /ADV Institution | $213.3K 7.5K shares |
THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. Private Equity | $30.3K 1.1K shares |
MATHER GROUP, INC. RIA/Wealth | $28.4K 1.0K shares |
| Institution | Previous Position |
|---|---|
UBS GLOBAL ASSET MANAGEMENT AMERICAS INC Long Only Manager | $5.8M 320.8K shares |
A AXA Institution | $4.4M 242.9K shares |
FIRST TRUST ADVISORS LP ETF Provider | $2.4M 131.4K shares |
A ALPS ADVISORS INC ETF Provider | $1.1M 60.6K shares |
Exome Asset Management LLC Hedge Fund•Sector | $662.4K 36.6K shares |
TWO SIGMA INVESTMENTS LLC Hedge Fund•Multi-Strategy | $514.2K 28.4K shares |
MILLENNIUM MANAGEMENT LLC Hedge Fund•Multi-Strategy | $495.2K 27.3K shares |
H HRT FINANCIAL LLC Institution | $474.6K 26.2K shares |
ALGERT COLDIRON INVESTORS LLC Hedge Fund•Quant | $328.5K 18.1K shares |
SPRINGBOK CAPITAL MANAGEMENT, LLC Fund of Funds | $243.0K 13.4K shares |
Institutions with the largest Call and Put options positions in NAMS as of Q3 2025
| Institution | Position Value |
|---|---|
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $1.3M 444.0 contracts |
Rock Springs Capital Management LP Hedge Fund•Sector | $898.7K 316.0 contracts |
Caption Management, LLC Hedge Fund•Long/Short | $315.7K 111.0 contracts |
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | - - contracts |
| Institution | Position Value |
|---|---|
Caption Management, LLC Hedge Fund•Long/Short | $33.3M 11.7K contracts |
Integral Health Asset Management, LLC Hedge Fund•Sector | $28.4M 10.0K contracts |
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $3.9M 1.4K contracts |
J JANE STREET GROUP, LLC Institution | $2.1M 724.0 contracts |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $972.6K 342.0 contracts |
Hudson Bay Capital Management LP Hedge Fund•Multi-Strategy | - - contracts |
Institutions with NAMS as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
FCPM III SERVICES B.V. Real Assets | 52.36% $262.0M |
B Bain Capital Life Sciences Investors, LLC Institution | 20.26% $304.9M |
Frazier Life Sciences Management, L.P. Venture Capital | 14.23% $475.0M |
M Medicxi Ventures Management Ltd Institution | 10.96% $81.6M |
C Cormorant Asset Management, LLC Hedge Fund•Long/Short | 4.82% $61.9M |
RA CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | 3.58% $288.4M |
Decheng Capital LLC Venture Capital | 3.26% $18.7M |
F First Turn Management, LLC Hedge Fund•Long/Short | 3.06% $20.4M |
D DCF Advisers, LLC Institution | 2.35% $5.0M |
H HealthInvest Partners AB Institution | 2.29% $584.6K |
Discover hedge funds investing in NAMS
| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
ETF ETF | $61.1M | 6.10% | |
Software - Infrastructure Technology | $54.5M | 5.44% | |
Medical - Diagnostics & Research Healthcare | $47.6M | 4.75% |
We use cookies for analytics. See our Privacy and Cookie Policy.